The deep penetrating power of the Identafi® 3000 ultra’s multiple wavelengths will enhance diagnostic efficacy as an adjunctive tool for early detection.
Trimira’s® new Identafi® 3000 ultra uses the Identafi® Multi-Spectral Fluorescence and Reflectance technology to enhance visualization of mucosal abnormalities such as oral cancer or premalignant dysplasia that may not be apparent to the naked eye. But unlike other fluorescence technologies and dye systems, the Identafi® 3000 ultra is Multi-Spectral with three distinct color wavelengths, making it easier to distinguish lesion morphology and vasculature thereby reducing false positives.
How It Works:
The Identafi® 3000 ultra uses white, violet and amber wavelengths of light to excite oral tissue in distinct and unique ways. As a result, biochemical changes can be monitored with fluorescence, while morphological changes can be monitored with reflectance. The combined system of fluorescence and reflectance uses the body’s natural tissue properties as an adjunctive tool for oral mucosal examination. Conventional examination of tissue is performed using a highly concentrated White light.
Wearing reusable Identafi® 3000 ultra filtered eyewear to enhance visual effects and allow transmission of reflected light, the health professional then switches to Violet for a second observation.
The clinician’s photosensitive glasses block the violet excitation light and allow the observance of the tissues natural fluorescence. Violet light enhances normal tissue’s natural fluorescence; however, suspicious tissue appears dark because of its loss of fluorescence.
When suspect abnormalities are present the selector is switched to Amber light, which enhances normal tissue’s reflectance properties so the clinician may directly observe the difference between normal and abnormal tissue’s vasculature. This independent view of vascular architecture may assist in the assessment of confounders when screening and diagnosing oral cancer.
Studies indicate abnormal tissue has a diffuse vasculature, where normal tissue vasculature is clearly defined. The combination of all three Multi-Spectral wavelengths provides the clinician with more visual information, improved results over direct visual exam alone and increased confidence for recommending biopsies.
THE NEED FOR EARLY DETECTION IS AVAILABLE TO ALL FRONT LINE CLINICIANS
The Identafi® 3000 ultra is intended for use by:
Dentists and Hygenists (early diagnosis)
Primary Care Practitioners (early diagnosis)
Oral Surgeons (early diagnosis)
ENT Head and Neck Surgeons, (to help identify diseased tissue around a clinically apparent lesion. The Identafi® 3000 ultra can enhance the surgeon’s ability to choose biopsy sites and aid in determining the appropriate margin for surgical incision
.
